key: cord-1042600-nsbj1amw
authors: Tang, Sun; Ou, Jing; Li, Rui; Zhang, Xiao-ming; Chen, Tian-wu; Li, Hong-jun
title: Changes in CT manifestations and RT-PCR testing of the coronavirus disease 2019 until recovery in patients with afferent infection vs. second-generation infection outside the original city (Wuhan): an observational study
date: 2020-08-08
journal: Radiol Infect Dis
DOI: 10.1016/j.jrid.2020.07.007
sha: 55675259f901a6cd033fe31b90dbb8f3f2806a75
doc_id: 1042600
cord_uid: nsbj1amw

Abstract Objective To investigate changes in CT manifestations and results of reverse transcription polymerase chain reaction (RT-PCR) testing between afferent and second-generation coronavirus disease 2019 (COVID-19) outside the original city (Wuhan) until recovery. Methods We collected 26 consecutive COVID-19 patients undergoing initial and follow-up CT scans together with RT-PCR until recovery from 2 hospitals outside the original city. Seventeen patients with afferent infection and 9 with second-generation infection were assigned to Group A and B, respectively. By observing CT manifestations, we scored COVID-19, and statistically analyzed numbers of patients with changes in CT scores and RT-PCR results between stages. Results The total score of COVID-19 on initial CT manifestations was higher in Group A than in Group B (P < 0.05). COVID-19 progressed more frequently from stage 1 to 2, and relieved from stage 3 to 4 in Group A (P < 0.05). The similar trend in Group A could not be found in Group B. Results of RT-PCR in most of patients in Group A turned negative at stage 4 while those in Group B turned negative at stage 3 (P < 0.05). Conclusion Changes in CT manifestation and RT-PCR result can be different between afferent and second-generation COVID-19 until recovery.

In December 2019, an outbreak of the coronavirus disease 2019 (COVID-19) 14 occurred in Wuhan, Hubei Province, China [1, 2] ; this unprecedented coronavirus that 15 caused COVID-19 was named SARS-CoV-2 (originally tentatively named 2019-nCoV) 16 [3]. Having spread rapidly to all provinces within China and across the world, centering 17 on Wuhan City (the original city of COVID-19), it has developed into a pandemic [4] . 18 Current research shows that the source of infection was mainly patients with COVID-19, 19 and the main route of transmission was transmission through respiratory tract and close infection. Therefore, our study aimed to investigate the changes of CT manifestations and 10 RT-PCR testing results until recovery in patients with COVID-19 outside the original city 11 between different origins of the infection. informed consent was obtained from each participant before the study. was 22.6 ± 6.6 days (range, 12-39 days) in Group A, and 16.5 ± 2.9 days (range, 11-20 1 days) in Group B. In addition, 2 patients in Group A were critically ill, and underwent 2 extended hospital stays relative to the other patients. During treatment, all patients needed 3 to undergo thoracic CT examinations and RT-PCR testing every 3-4 days to assess 4 changes of COVID-19 so as to evaluate the efficacy of anti-viral therapy until recovery.

All patients underwent their first CT examinations and RT-PCR testing on the day of 6 hospitalization. In our cohort, 17 patients underwent thoracic CT examination with 16-row 10 multidetector row CT (MDCT) system (uCT 510, United Imaging, Shanghai, China), and 11 the remaining 9 patients underwent thoracic CT scans with a 128-row multidetector CT 12 system (SOMATOM Definition Flash, Siemens Healthcare systems, Germany).

Following the usual position for thoracic CT scan, each patient was placed in a supine 14 position with arms raised and was asked to hold their breath during the CT examination. 15 The coverage of thoracic CT scans was from the thoracic inlet to the middle of the kidney, The thoracic CT data were analyzed as follows. As reported [11] [12] [13] [14] , COVID-19 can 29 be manifested as ground glass opacity (GGO), consolidation, and crazy-paving patterns and 22 years of experience in body CT study respectively) interpreted the image data in 1 consensus according to the above-mentioned CT manifestations. Because the time course 2 of COVID-19 was divided into 4 stages, comprising stages 1, 2, 3 and 4 according to the 3 relevant reported literature [15] , we compared number of the patients with the changes in 4 CT manifestations between 2 adjacent stages of the 4 stages in Group A and B, and 5 patients at stage 1 were compared with patients at admission. In addition, stage 1 was the 6 early stage (0-4 days after admission), stage 2 was the progressive stage (5-8 days after 7 admission), stage 3 was the peak stage (9-13 days after admission), and stage 4 was the 8 absorption stage (≥14 days after admission). Subsequently, the above-mentioned experienced radiologists (readers 1 and 2) 10 scored the lesions of COVID-19 on the initial CT at the time of hospitalization based on 11 the reported semi-quantitative scoring system [16] . According to the scoring system, the 12 lesions in each lung lobe were scored from 0 to 5 based on the extent of each lobe 13 involvement as follows: 0 was for no involvement; 1 was for the involvement of <5%; 2 14 was for 6%-25% involvement; 3 was for 26%-49% involvement; 4 was for 50%-75% 15 involvement; and 5 was for >75 % involvement. The total CT score, with the minimum of Table 1 . Based on the CT scores obtained on the initial CT data, the total score of COVID-19 was 10 (range, 7 to 21) in Group A, and 6 (range, 0-15) in 1 Group B. Statistics showed that the total score of COVID-19 was significant higher in 2 Group A than in Group B (P = 0.038).

Based on the comparisons of total score of COVID-19 obtained on follow-up CT 4 scans during treatments between adjacent stages, the progressive and relieved patients in 5 Group A and B are illustrated in Table 2 . In Group A, statistics showed that COVID-19 6 progressed more frequently in patients with afferent infection from stage 1 to 2, and 7 relieved more frequently from stage 3 to 4 (P < 0.05). The similar trend in Group A could 8 not be found in Group B.

In addition, there were no statistical differences in gender and age of patients with 10 COVID-19 between Group A and B after statistical analyses, while statistics showed that 11 the time course in Group A was longer than in Group B (P = 0.02). Table 3 . of critical type would be very few outside the original city (Wuhan). This can be 2 explained by the virus load or the chance of being exposed to the virus in the 3 environment of the districts outside the original city (Wuhan) being much lower than in 4 the previous original city. 5 We found that the CT manifestations of COVID-19 in patients with afferent J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f A (n = 17) Relieved cases 0 1 (5.8%) 2 (11.8%) 8 (47%)

Progressive cases 0 2 (11.8%) 2 (11.8%) 2 (11.8%) B (n = 9) Relieved cases 0 1 (11.1%) 5 (55.6%) 1 (11.1%)

A Novel Coronavirus 14 from Patients with Pneumonia in China

Novel coronavirus 16 (SARS-CoV-2) epidemic: a veterinary perspective

Preliminary Identification of Potential Vaccine 18 Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV 19

Coronavirus Emerging in China -Key Questions for Impact Assessment

CT imaging of two cases of 4 one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: inconsistency 5 between clinical symptoms amelioration and imaging sign progression

Chest CT for Typical 8 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

Imaging of pulmonary viral pneumonia

Radiographics and CT 13 Features of Viral Pneumonia

Fleischner Society: glossary of terms for thoracic imaging

CT Imaging of the 2019 Novel Coronavirus 18 (2019-nCoV) Pneumonia

Changes On Chest CT During Recovery From 2019 Novel Coronavirus

Pulmonary 23 sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with 24 thin-section CT

Clinical Characteristics